Amundi’s Collegium Pharmaceutical COLL Stock Holding History

Amundi’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$270K	Buy	+8,156	New	+$345K	﹤0.01%	1783
2025 Q4	–	Sell	-185,524	Closed	-$6.28M	–	1850
2025 Q3	$6.28M	Buy	+185,524	New	+$6.45M	﹤0.01%	925
2025 Q2	–	Sell	-62,592	Closed	-$1.82M	–	1775
2025 Q1	$1.82M	Buy	62,592 +47,024	+302%	+$1.44M	﹤0.01%	1177
2024 Q4	$519K	Buy	15,568 +10,168	+188%	+$336K	﹤0.01%	1560
2024 Q3	$205K	Buy	5,400 +504	+10%	+$18K	﹤0.01%	1656
2024 Q2	$158K	Buy	+4,896	New	+$170K	﹤0.01%	1622
2023 Q2	–	Sell	-4,586	Closed	-$108K	–	2048
2023 Q1	$108K	Buy	+4,586	New	+$122K	﹤0.01%	1720

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Amundi's COLL Position: Q1 2026 in Review

Amundi opened a new position in Collegium Pharmaceutical (COLL) in Q1 2026: 8,156 shares worth $270K. The stake represents ﹤0.01% of the portfolio and ranks #1783 among its holdings. This is a return to the name: Amundi previously reported a position in COLL as recently as Q3 2025.

Amundi first reported a position in COLL in Q1 2023 and has held it in 7 quarters since. The position peaked at $6.28M in Q3 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

Amundi held 8,156 shares of Collegium Pharmaceutical worth $270K as of Q1 2026.
Collegium Pharmaceutical was a new Amundi position in Q1 2026.
Collegium Pharmaceutical made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1783 holding.
Amundi first reported a position in Collegium Pharmaceutical in Q1 2023 and has held it in 7 quarters since.
Amundi's Collegium Pharmaceutical position peaked at $6.28M in Q3 2025.
266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.